Government Extends Deadline as Pharma Upgrade Scheme Faces Compliance Delays
The government's Revamped Pharmaceutical Technology Upgradation Assistance Scheme (RPTUAS) aims to support MSME pharma units in meeting revised manufacturing norms under Schedule M and WHO-GMP. However, only 18 of the 301 approved units have received incentives due to delays in compliance and certification. The government has extended the deadline to December 2025 and is addressing operational challenges faced by smaller manufacturers to improve uptake and adherence to the updated standards.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (49/100). Lens Score 41/100.
Outlets measured: thefinancialexpress, thefinancialexpress. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (48–50/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
thefinancialexpress broke this story on 9 Aug, 12:56 pm. Other outlets followed.
- 1